SCHOTT MINIFAB
SCHOTT MINIFAB is a SCHOTT AG business unit that designs, develops, and manufactures microfluidic devices, microarrays, and diagnostic consumables as a CDMO for IVD manufacturers and life science research institutions, operating production facilities in the USA, Germany, and Australia.
- Company typePrivate
- Founded2003
- HeadquartersMelbourne, Australia
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What SCHOTT MINIFAB does
SCHOTT MINIFAB is a contract design, development, and manufacturing organization (CDMO) and a business unit of SCHOTT AG, specializing in microfluidic devices, microarrays, and consumables for the in vitro diagnostics (IVD) and life science research markets. The company serves IVD manufacturers developing tools for infectious disease detection, point-of-care diagnostics, molecular diagnostics, immunological diagnostics, and lab-on-a-chip applications, as well as life science research institutions working on next-generation research tools including NGS, protein, and DNA microarrays. It is based in Melbourne, Australia with production facilities in Phoenix (USA), Jena (Germany), and Melbourne, and operates with 101-250 employees.
The company's product platform rests on three proprietary technology brands. SCHOTT® Microarrays is a microarray printing platform pioneered over two decades ago in response to the Human Genome Project and refined continuously since. NEXTERION® is the registered glass substrate family, offered in coated variants for DNA and protein microarrays, bonded variants for microfluidic and NGS applications, and structured variants for customized biochip sizes. SCHOTT® Reagent Blister is a high gas-barrier, chemically compatible reagent storage technology that integrates dry/wet assay reagents directly onto consumables.
SCHOTT MINIFAB makes money through two primary service streams: contract product development (a Stage Gate Process from concept to commercialization covering R&D support, prototype feasibility, and manufacturing infrastructure development) and contract manufacturing (pilot lines through fully automated high-volume production), complemented by pilot line services, precision injection molding, and microfluidics solutions. Pricing is quote-based and not publicly disclosed, with all customer relationships established through direct B2B enterprise engagement via a quote request form on the company website. In September 2021, SCHOTT AG acquired Applied Microarrays Inc. (AMI) in Arizona to expand US bioscience capacity, and SCHOTT MINIFAB is wholly owned through SCHOTT AG, which is itself owned by the Carl Zeiss Foundation.
SCHOTT MINIFAB firmographics
Firmographics- Name
- SCHOTT MINIFAB
- Legal name
- SCHOTT MINIFAB
- Website
- https://schott-minifab.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- SCHOTT MINIFAB is a SCHOTT AG business unit that designs, develops, and manufactures microfluidic devices, microarrays, and diagnostic consumables as a CDMO for IVD manufacturers and life science research institutions, operating production facilities in the USA, Germany, and Australia.
- Ownership category
- akta.pro rank
SCHOTT MINIFAB industry classification
Industry- Product category
- Diagnostic and Life Science Consumables Manufacturing
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Plastics Products, Nec (3089)
- akta.pro primary industry
- Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)
- akta.pro secondary industry
- GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)
Keywords
Where SCHOTT MINIFAB is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Offices3 records
Markets served
SCHOTT MINIFAB business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Contract Product Development: Stage-gate development services supporting customers from concept through commercialization, including R&D phase support, prototype development for feasibility studies, and scalable manufacturing infrastructure development.
- Contract Manufacturing: Manufacturing services ranging from low-volume pilot lines using purpose-built infrastructure to fully automated high-volume production for diagnostic and life science research consumables.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
SCHOTT MINIFAB product offering
Product offeringCore offering
SCHOTT MINIFAB is a contract design, development, and manufacturing organization (CDMO) that produces microfluidic devices and consumables for in vitro diagnostics and life science research. It manufactures physical products including SCHOTT® Microarrays, NEXTERION® glass substrates, and SCHOTT® Reagent Blisters, and provides contract product development, contract manufacturing, pilot line, precision injection molding, and microfluidics services from facilities in Phoenix (USA), Jena (Germany), and Melbourne (Australia).
Product overview
SCHOTT MINIFAB is a contract design, development, and manufacturing company specializing in in vitro diagnostics and life science research consumables. The company operates a platform of physical products including SCHOTT® Microarrays (pioneered over 20 years ago for the Human Genome Project), NEXTERION® glass substrates (available in bonded, coated, and structured variants for biochip, microfluidic, and lab-on-chip applications), and SCHOTT® Reagent Blister technology for reagent containment. These products are complemented by comprehensive services including contract product development (Concept to Commercialization stage gate process), contract manufacturing (from pilot lines to high-volume automated production), pilot line services, precision injection molding, and microfluidics solutions. The company maintains production facilities in Phoenix (USA), Jena (Germany), and Melbourne (Australia).
Differentiator
Problem solved
Functional benefit
Brands
- SCHOTT® Microarrays: Pioneered over two decades ago in response to the Human Genome Project, SCHOTT® Microarrays have been refined into a comprehensive microarray printing platform for biosensor and diagnostic applications.
- NEXTERION®
- SCHOTT® Reagent Blister
Products and services
- SCHOTT® Microarrays A microarray printing platform offering comprehensive DNA and protein microarray solutions for diagnostics and life science applications; targeted at IVD manufacturers and life science research organizations.
- NEXTERION® Glass Substrates Glass substrate product line (bonded, coated, and structured variants) for biochip, microfluidic, lab-on-chip, molecular diagnostics, immunological diagnostics, and life science research applications; targeted at diagnostics manufacturers and research tool developers.
- SCHOTT® Reagent Blister Blister-based reagent storage technology that integrates assay reagents onto IVD and life science consumables using high gas barrier, chemically and biologically compatible materials; targeted at IVD manufacturers and diagnostics developers.
- Contract Product Development Stage gate (Concept to Commercialization) development services spanning R&D support, prototype feasibility studies, and scalable manufacturing infrastructure development for diagnostic and life science consumables; targeted at product developers and IVD manufacturers.
- Contract Manufacturing Manufacturing services ranging from low-volume pilot line production to fully automated high-volume production for diagnostic and life science research consumables; targeted at IVD manufacturers and life science research organizations.
- Pilot Line Services Pilot line services supporting small-scale production and process validation for diagnostic and life science consumables prior to full-scale manufacturing; targeted at IVD product developers.
- Precision Injection Molding Solutions Precision injection molding services for high-volume manufacturing of diagnostic and life science consumables; targeted at IVD manufacturers and life science research consumables producers.
- Microfluidics Solutions Microfluidics design, development, and manufacturing solutions including lab-on-a-chip technology for diagnostic and life science applications; targeted at IVD manufacturers and point-of-care diagnostics developers.
Quantifiable outcome
- Seamless transition from concept to commercialization through Stage Gate Process
Companies that use SCHOTT MINIFAB
Customer profileSegments2 records
Ideal customer profiles2 records
SCHOTT MINIFAB technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
SCHOTT MINIFAB partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Applied Microarrays Inc. (AMI)coreSCHOTT signed an agreement to acquire Applied Microarrays Inc. (AMI), a microarray solutions company based in Arizona, to expand bioscience capabilities and manufacturing presence in the United States. The acquisition enhances SCHOTT's microarray printing and biosensor capabilities, especially for point-of-care diagnostics such as infectious disease detection.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
SCHOTT MINIFAB competitors and assessment
Company assessmentDirect peers
- Bio-Rad Laboratories: Bio-Rad manufactures life science research and clinical diagnostics consumables, including digital PCR, qPCR, microarray, and flow cytometry products. Directly comparable to SCHOTT MINIFAB as a developer and manufacturer of IVD and life science research consumables serving overlapping customer segments.
- Standard BioTools (formerly Fluidigm): Standard BioTools designs and manufactures microfluidic-based consumables and instruments for proteomics, genomics, and single-cell analysis. Highly comparable to SCHOTT MINIFAB's microarray/microfluidic consumables business with similar customer base in life science research.
- Bio-Techne: Bio-Techne develops and manufactures reagents, assay kits, and proprietary platforms for life science research and diagnostics. Comparable to SCHOTT MINIFAB in serving IVD and life sciences with specialized consumables, microarrays, and contract capabilities.
- STRATEC Biomedical: STRATEC is a leading contract development and manufacturing partner for IVD and life science instrumentation and consumables. Direct CDMO peer to SCHOTT MINIFAB serving in vitro diagnostics manufacturers with development and manufacturing services.
Broad incumbents
- Agilent Technologies: Agilent is a broad analytical instruments and life sciences consumables provider with microarray, genomics, and diagnostics offerings. Comparable to SCHOTT MINIFAB as a larger incumbent with microarray and life science tools capabilities, though much broader in scope.
- Thermo Fisher Scientific: Thermo Fisher is the largest life sciences tools and services provider with a comprehensive microarray, IVD, and CDMO portfolio. Comparable to SCHOTT MINIFAB as a dominant incumbent offering microarray/IVD consumables and contract manufacturing at much greater scale.
- Danaher: Danaher owns multiple diagnostics and life sciences businesses (Beckman Coulter, Cepheid, Leica, Cytiva). Comparable to SCHOTT MINIFAB as a diversified diagnostics and life sciences consumables parent with significant CDMO exposure via Cytiva.
- Sartorius AG: Sartorius provides bioprocessing and lab consumables, including CDMO and contract manufacturing services for life sciences. Comparable to SCHOTT MINIFAB as a broader life science tools/CDMO player serving IVD and life sciences customers.
- PerkinElmer: PerkinElmer (now split into Revvity and the applied sciences business) provides life sciences, diagnostics, and analytical instruments including microarray and microfluidic products. Comparable to SCHOTT MINIFAB as an incumbent with overlapping microarray and diagnostics consumables capabilities.
Emerging players
- 10x Genomics: 10x Genomics develops single-cell and spatial genomics consumables and instruments using proprietary microfluidic barcode technology. Comparable to SCHOTT MINIFAB's microfluidic consumables capabilities, though specialized to single-cell and spatial genomics workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
SCHOTT MINIFAB social profiles
Digital presenceSCHOTT MINIFAB financial estimates
Financial estimateRevenue estimate
Valuation estimate
SCHOTT MINIFAB leadership team
Management profileNumber of profiles
Profiles1 record
SCHOTT MINIFAB subsidiaries and ownership
Company hierarchySubsidiaries1 record
SCHOTT MINIFAB funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SCHOTT MINIFAB M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SCHOTT MINIFAB
What does SCHOTT MINIFAB do?
SCHOTT MINIFAB is a contract design, development, and manufacturing organization (CDMO) that produces microfluidic devices and consumables for in vitro diagnostics and life science research. It manufactures physical products including SCHOTT® Microarrays, NEXTERION® glass substrates, and SCHOTT® Reagent Blisters, and provides contract product development, contract manufacturing, pilot line, precision injection molding, and microfluidics services from facilities in Phoenix (USA), Jena (Germany), and Melbourne (Australia).
Is SCHOTT MINIFAB a public or private company?
SCHOTT MINIFAB is a private company. It is classified as corporate owned and is currently operating.
When was SCHOTT MINIFAB founded?
SCHOTT MINIFAB was founded in 2003. It employs 101 to 250 people.
Where is SCHOTT MINIFAB based?
SCHOTT MINIFAB is headquartered in Melbourne, Australia, in the Oceania region.
How does SCHOTT MINIFAB make money?
Two revenue lines are on record. Contract Product Development is the primary driver. The others are contract Manufacturing.
Who are SCHOTT MINIFAB's main competitors?
Direct peers on record are Bio-Rad Laboratories, Standard BioTools (formerly Fluidigm), Bio-Techne and STRATEC Biomedical. Broad incumbents are Agilent Technologies, Thermo Fisher Scientific, Danaher, Sartorius AG and PerkinElmer. 10x Genomics is listed as an emerging player.
Does SCHOTT MINIFAB have an API?
No public API is recorded for SCHOTT MINIFAB.
What industry is SCHOTT MINIFAB in?
SCHOTT MINIFAB's product category is Diagnostic and Life Science Consumables Manufacturing. Its primary akta.pro industry code is HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO, with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 3391 and its SIC code is 3089.